Gilde Healthcare


Gilde Healthcare is a specialized healthcare investor managing over €2.6 billion across two fund strategies: Venture&Growth and Private Equity. The firm focuses on investing in businesses that enable better care at lower cost, with a strong presence in Europe and North America. Gilde Healthcare is headquartered in Utrecht, the Netherlands, with additional offices in Frankfurt, Germany, and Boston, USA.

Gilde Healthcare

Gilde Healthcare


Portfolio

Essange Reagents is an international developer and manufacturer of reagents for in-vitro diagnostics.

#In-vitro diagnostics

The Scharenborg Group is an integrated provider of footcare, offering podological services.

#Footcare technology

Novicare provides specialized medical and paramedical (tele)care for elderly patients and people with disabilities.

#Healthcare services

Jecture specializes in the development and contract manufacturing of custom, complex cannulas and cannula systems for pharmaceutical applications.

#Medical devices

Viroclinics Biosciences is a leading service provider for diagnostics and clinical studies.

#Diagnostics and clinical trials

KLIFO is a leading consultancy in drug development with extensive experience.

#Pharmaceutical consulting

Performation is a provider of business intelligence solutions for healthcare, with a focus on software products.

#Healthcare IT

Pharmaline is a specialized manufacturer of non-registered pharmaceutical products.

#Pharmaceutical manufacturing

Stepping Stones operates high-quality private elderly and care homes with specialized 24-hour care and support services.

#Elderly care

Prosonix is a manufacturer of specialty pharmaceutical products with a focus on generic respiratory preparations.

#Pharmaceuticals

Chroma Therapeutics discovers and develops novel small molecule drugs for the treatment of common cancers and inflammatory diseases.

#Biotechnology

Symphogen is a leader in the development of antibody mixtures to improve cancer treatment.

#Biotechnology

Purespring is a groundbreaking gene therapy company focused on kidney diseases.

#Gene therapy

Nyxoah S.A. is a Belgian healthtech company developing innovative solutions for sleep apnea.

#Healthtech

ADCendo is a Danish biopharmaceutical company developing antibody-drug conjugates (ADCs) for cancer treatment.

#Biopharmaceuticals

Santaris Pharma researches and develops RNA-targeted therapies for infectious diseases and metabolic disorders.

#Biotechnology

Volta Medical is a medical technology company founded by cardiologists and a data scientist, focusing on cardiac care.

#Medical technology

MicroTransponder is a fast-growing US company marketing the Vivistim Paired VNS System for stroke recovery.

#Medical devices

GT Medical Technologies, Inc. is a medical device company focused on improving the lives of patients with brain tumors, recently raising $37 million in a Series D financing round.

#Medical devices

Alleviant Medical, Inc. is developing a no-implant atrial shunt for heart failure, securing $90 million in financing to expand its pivotal trial program.

#Medical devices

FIRE1 is focused on revolutionizing heart failure care, completing a $120 million financing round.

#Medical devices

SpliceBio is a clinical-stage genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes, with its SB-007 receiving U.S. FDA IND clearance.

#Biotechnology

Noema Pharma is a clinical-stage biotech company targeting CNS disorders, extending its Series B financing round to CHF 130 million.

#Biotechnology

Shoulder Innovations is a leader in shoulder replacement technology, closing a $40 million Series E equity financing round.

#Medical devices